Philip A Goliber
Inventor
Stats
- 5 US patents issued
- 10 US Applications filed
- most recent filing
This is official USPTO record data
Details
- 5 US Patents Issued
- 10 US Applications Filed
- 146 Total Citation Count
- Nov 21, 2018 Most Recent Filing
- Aug 25, 2005 Earliest Filing
Work History
Patent Owner | Applications Filed | Year |
---|---|---|
PENWEST PHARMACEUTICALS COMPANY | 1
| 2006
|
ENDO PHARMACEUTICALS INC. | 2
2 2 4 1 | 2006
2008 2013 2014 2016 |
EURO-CELTIQUE S.A. | 1
| 2005
|
Inventor Addresses
Address | Duration |
---|---|
Brookfield, CT | Apr 06, 06 - May 10, 07 |
Brookfield, CT, US | Jul 08, 14 - Jul 08, 14 |
LASNE, BE | Jun 27, 13 - Jun 27, 13 |
Lasne, BE | Jan 29, 09 - Sep 10, 19 |
Technology Profile
Technology | Matters | |
---|---|---|
A01N: | PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF | 3 |
A61K: | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | 10 |
A61P: | THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS | 1 |
Patents / Publication
Patents / Publication # | Year of Publication / Issued | Title | Citations |
---|---|---|---|
10406106 | 2019 | Sustained release formulations of nalbuphine | 0 |
2019/0117,576 | 2019 | SUSTAINED RELEASE FORMULATIONS OF NALBUPHINE | 0 |
10172798 | 2019 | Sustained release formulation of nalbuphine | 0 |
2018/0042,852 | 2018 | SUSTAINED RELEASE FORMULATION OF NALBUPHINE | 0 |
2016/0263,035 | 2016 | SUSTAINED RELEASE FORMULATION OF NALBUPHINE | 0 |
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
>
Upgrade to our Level for up to -1 portfolios!.